Tools to mitigate disease associated with Streptococcus zooepidemicus: an emerging threat to the Canadian pork industry

减轻兽疫链球菌相关疾病的工具:对加拿大猪肉业的新威胁

基本信息

  • 批准号:
    561369-2020
  • 负责人:
  • 金额:
    $ 4.08万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Alliance Grants
  • 财政年份:
    2021
  • 资助国家:
    加拿大
  • 起止时间:
    2021-01-01 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

Since spring 2019, multiple cases of sow mortality (>50%, sudden death with minimal respiratory signs) and abortions (11 times higher than normal) have been reported in Canada and the USA. These cases were definitively associated with Streptococcus equi subspecies zooepidemicus (S. zoo), which is now considered an emerging threat to the North American pork industry. Our team responded to the first cases in Canada, characterizing the bacteria and supporting veterinarians and the industry with the development of diagnostic tests. Preliminary field trials using standard autogenous vaccines did not result in protection against infection. Thus, current tools to control the disease in affected farms are limited to depopulation, which is estimated to cost over CAD $15 million in larger production systems. Moving forward, to prevent further losses across Canada, the development of efficient preventive and control methods is critical.The goal of the work proposed here is to investigate the development of tools for the prevention and control of S. zoo, to reduce disease severity in pigs and potentially prevent infection. We will employ cutting edge research tools (e.g. transcriptomics) to characterize how and where S. zoo infects pigs, and employ this knowledge to develop a vaccine or non-antibiotic compounds that will protect pigs from infection and reduce deaths.
自2019年春季以来,加拿大和美国报告了多起母猪死亡(50%,猝死,呼吸症状轻微)和流产(比正常情况高出11倍)的病例。这些病例被明确地与马链球菌动物流行亚种(S.zoo)联系在一起,它现在被认为是对北美猪肉行业的新威胁。我们的团队对加拿大的第一批病例做出了反应,确定了细菌的特征,并通过诊断测试的开发为兽医和行业提供支持。使用标准自体疫苗的初步现场试验并未产生预防感染的效果。因此,目前在受影响农场控制疾病的工具仅限于减少人口,在更大的生产系统中估计要花费超过1500万加元。展望未来,为了防止加拿大各地的进一步损失,开发有效的预防和控制方法是至关重要的。这里提出的工作目标是调查预防和控制S.zoo的工具的开发,以降低猪的疾病严重程度,并潜在地预防感染。我们将使用尖端研究工具(例如转录学)来描述S.zoo感染猪的方式和地点,并利用这一知识开发疫苗或非抗生素化合物,以保护猪免受感染并减少死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Costa, Matheus其他文献

Costa, Matheus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Costa, Matheus', 18)}}的其他基金

Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections
肠道宿主-微生物组-病原体相互作用:了解细菌感染的病理生理学
  • 批准号:
    RGPIN-2020-06353
  • 财政年份:
    2022
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Discovery Grants Program - Individual
Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections
肠道宿主-微生物组-病原体相互作用:了解细菌感染的病理生理学
  • 批准号:
    RGPIN-2020-06353
  • 财政年份:
    2021
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Discovery Grants Program - Individual
Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections
肠道宿主-微生物组-病原体相互作用:了解细菌感染的病理生理学
  • 批准号:
    DGECR-2020-00137
  • 财政年份:
    2020
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Discovery Launch Supplement
Gut host-microbiome-pathogen interaction: understanding the pathophysiology of bacterial infections
肠道宿主-微生物组-病原体相互作用:了解细菌感染的病理生理学
  • 批准号:
    RGPIN-2020-06353
  • 财政年份:
    2020
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Discovery Grants Program - Individual

相似海外基金

Non-nutritive sweetener consumption during pregnancy and child body mass index: can postnatal fibre consumption mitigate potential risks?
怀孕期间的非营养性甜味剂消费和儿童体重指数:产后纤维消费可以减轻潜在风险吗?
  • 批准号:
    488069
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Operating Grants
Resistance exercise to mitigate glucocorticoid myopathy during Alzheimer’s
抗阻运动可减轻阿尔茨海默病期间的糖皮质激素肌病
  • 批准号:
    10667849
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Non-invasive vagus nerve stimulation to mitigate subarachnoid hemorrhage induced inflammation
无创迷走神经刺激减轻蛛网膜下腔出血引起的炎症
  • 批准号:
    10665166
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Time Restricted Eating to Mitigate Obesity in Veterans with Spinal Cord Injury
限制时间饮食以减轻脊髓损伤退伍军人的肥胖
  • 批准号:
    10752306
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Nitrite Supplementation to Mitigate Fatigability and Increase Function in Long COVID Patients
补充亚硝酸盐可减轻长期新冠患者的疲劳并增强功能
  • 批准号:
    10590380
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
  • 批准号:
    10734981
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure
改善炎症消退以减轻获得性骨髓衰竭
  • 批准号:
    10595109
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Restoration of vascular endothelial cell function as a novel strategy to mitigate T2D-associated cardiovascular disease.
恢复血管内皮细胞功能作为减轻 T2D 相关心血管疾病的新策略。
  • 批准号:
    478125
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
    Operating Grants
HippoCamera: A neuroscience-guided smartphone intervention to mitigate age-related memory loss
HippoCamera:一种神经科学指导的智能手机干预措施,可减轻与年龄相关的记忆丧失
  • 批准号:
    497932
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation
通过微生物生物转化减轻外源毒性的新型益生菌
  • 批准号:
    10707553
  • 财政年份:
    2023
  • 资助金额:
    $ 4.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了